A Study Of GEDC Data Repository
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 25-002745
About this study
The main purpose of the database is to create and maintain an analysis-ready limited data set from multiple healthcare centers, including continuously updated data from electronic medical records and a linked prospective dataset which was previously collected through an NYULH IRB-approved multi-site research study (i24-00287 - GEARSS).
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
RETROSPECTIVE cohort: To be eligible for inclusion in the Database, an individual must meet all the following criteria:
PROSPECTIVE cohort: To be eligible for inclusion in the Database, an individual must meet all the following criteria:
Exclusion Criteria:
RETROSPECTIVE cohort: An individual meeting any of the following criteria will be excluded from inclusion:
PROSPECTIVE cohort: An individual meeting any of the following criteria will be excluded from inclusion:
Exclusionary criteria and accommodations for participants with impaired decision-making capacity within the GEARSS study were approved under NYULH IRB i24-00287 which closed to recruiting and enrollment in June 2022. There will be no additional prospective data collection.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 7/14/2025. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Molly Jeffery, Ph.D. |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available